^
    BIOMARKER:
    RET rearrangement
    i
    Other names: RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1
    Entrez ID:
    5979
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    RET rearrangement
    NSCLC
    cabozantinib tablet
    Sensitive
    :
    A2
    RET rearrangement
    NSCLC
    vandetanib
    Sensitive
    :
    A2
    RET rearrangement
    NSCLC
    selpercatinib
    Sensitive
    :
    A2
    RET rearrangement
    NSCLC
    pralsetinib
    Sensitive
    :
    A2
    RET rearrangement
    NSCLC
    alectinib
    Sensitive
    :
    C2
    RET rearrangement
    NSCLC
    sunitinib
    Sensitive
    :
    C2
    RET rearrangement
    NSCLC
    selpercatinib + pralsetinib
    Sensitive
    :
    C3
    RET rearrangement
    LUAD
    cabozantinib tablet
    Sensitive
    :
    C3
    RET rearrangement
    Thyroid Gland Carcinoma
    selumetinib
    Sensitive
    :
    D
    RET rearrangement
    Thyroid Gland Papillary Carcinoma
    MK-2206
    Sensitive
    :
    D
    RET rearrangement
    Thyroid Gland Carcinoma
    AZD1480
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES